782PSAFETY OF CABAZITAXEL + PREDNISONE (CBZ + P) IN...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

782PSAFETY OF CABAZITAXEL + PREDNISONE (CBZ + P) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (DOC): COHORT COMPASSIONATE-USE PROGRAMME (CUP)

Heidenreich, A., Scholz, H., Ozen, H., Pripatnanont, C., van Oort, I.M., Gerritsen, W.R., Efstathiou, E., Rinck, J.A., Lee, J., Boumessous, A., Su, Z., Hitier, S., Ardavanis, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu336.30
Date:
September, 2014
File:
PDF, 68 KB
2014
Conversion to is in progress
Conversion to is failed